Phebra

A sterile, clear, colourless, or almost colourless isotonic aqueous solution for injection or infusion containing bupivacaine hydrochloride and adrenaline (epinephrine) for local or regional anaesthesia and analgesia.

Bupivacaine hydrochloride 50 mg/20 mL with adrenaline (epinephrine) 50 microgram/20 mL solution for injection.

Metaraminol 0.5 mg/ml Solution for Injection/Infusion.

Metaraminol 0.5 mg/ml Solution for Injection/Infusion.

Metaraminol 10 mg/ml Solution for Injection/Infusion.

Phenasen concentrated solution for infusion containing arsenic trioxide.

Arsenic Trioxide Phebra solution for injection.

Phenasen concentrated solution for infusion containing arsenic trioxide.

Hypertonic concentrated injections for infusion used as an additive to parenteral fluids in patients who have specific electrolyte needs or as a sclerosing agent for small symptomatic varicose veins.

Sterile isotonic solution of sodium chloride in water for injections containing no preservatives.

Aramine injection is a clear colourless to slightly yellow/pink sterile solution of metaraminol tartrate equivalent to 10 mg/mL metaraminol, used for the prevention and treatment of acute hypotensive states.

Methylthioninium Chloride 10 mg/ml Sterile Concentrate for Solution for Injection.

Calcium Chloride 10% Injection is a clear, colourless sterile solution of calcium chloride dihydrate in Water for Injections BP indicated in the treatment of hypocalcaemia and to antagonise the cardiotoxicity of hyperkalaemia.

Each mL of Metaraminol Phebra solution for injection contains metaraminol (as tartrate) 0.5 mg, sodium chloride 9 mg, sodium metabisulfite 1.2 mg as antioxidant in water for injections to 1 mL.

A clear, colourless, slightly viscous, sterile solution containing magnesium sulfate heptahydrate 500mg per mL, used for parenteral administration.

Charcotrace Injection is a sterile suspension containing activated charcoal 120 mg and sodium chloride in water for injections, used as an aid in the stereotactic or ultrasonic localisation of small impalpable breast lesions.

Sodium Bicarbonate Injection is a sterile solution used as an alkalinising agent in the treatment of metabolic acidosis, to increase urinary ph, and in the treatment of certain intoxications.

A sterile, clear, practically colourless concentrated injection containing 50mg of glyceryl trinitrate in 10mL of solution.

Acetylcysteine 200 mg per mL sterile, pyrogen-free aqueous solution intended for intravenous administration as an antidote for paracetamol poisoning to protect against hepatotoxicity.

A sterile concentrated solution for injection containing 600 mg quinine dihydrochloride in 10 mL of water for injections, indicated for the acute treatment of malaria.

Charcotrace Injection is a sterile suspension containing activated charcoal 120 mg and sodium chloride in water for injections to 3 mL, used as an aid in stereotactic or ultrasonic localisation of small impalpable breast lesions.

Potassium chloride 2.23 g in water for injections to 10 mL. Each 10 mL contains 30 mmol potassium chloride or 30 mmol potassium ions and 30 mmol chloride ions.

Droleptan injection contains 2.5 mg/mL droperidol as the active ingredient, presented as a 1 mL solution in an ampoule used for tranquillisation, reducing nausea and vomiting, and management of severe agitation.

A sterile solution of methylene blue trihydrate used for the treatment of drug-induced or idiopathic methaemoglobinaemia, as a diagnostic dye, and for tissue delineation during surgery.

Digoxin-specific antibody fragment F(Ab) (Ovine) sterile, purified, lyophilized off-white powder used as an antidote for digoxin toxicity.

Glaumox is a sterile lyophilized powder of acetazolamide sodium provided in a rubber-capped vial, requiring reconstitution with water for injections for intravenous administration as an adjunctive treatment for conditions such as glaucoma, epilepsy, and congestive heart failure.

Each vial contains potassium phosphate monobasic 1.361 g in water for injections to 10 mL. Each 10 mL contains 10 mmol of potassium and 10 mmol of phosphate.

Calcium gluconate injection.

Each vial of Benzatropine Injection contains 2 mg of benzatropine mesilate as the active ingredient, sodium chloride and water for injections to 2 mL.

Prenoxad Solution for Injection contains naloxone hydrochloride 1 mg/mL to 2 mL in a prefilled syringe. It is a sterile, clear and colourless liquid intended for the complete or partial reversal of respiratory depression induced by natural and synthetic opioids.

Ibuprofen concentrated solution for injection.

Ergometrine and oxytocin injection.

Esmolol hydrochloride powder for injection for infusion.

Narcan Injection contains naloxone hydrochloride dihydrate and is indicated for the complete or partial reversal of opioid depression, including respiratory depression, and for the diagnosis of suspected acute opioid overdosage.

Prenoxad Injection is intended for emergency use in the home or other non-medical setting by appropriate individuals or in a health facility setting for the complete or partial reversal of respiratory depression induced by natural and synthetic opioids.

Digoxin-specific antibody fragment powder for injection.

Carbosorb X is a black, viscous suspension containing 0.2 g/mL activated charcoal, formulated for the treatment of poisoning and drug overdosage by oral ingestion.

Papaverine Phebra is a sterile, clear, colourless to pale-yellow solution of papaverine hydrochloride in water for injections, indicated for the treatment of erectile dysfunction.

Each vial of Cafnea Injection contains caffeine base 20 mg, citric acid monohydrate and sodium citrate in water for injections to 2 mL, equivalent to caffeine citrate 40 mg.

Powder for injection containing acetazolamide.

Colistimethate sodium powder for nebuliser solution.

Proladone suppositories contain oxycodone 30 mg for the relief of post-operative pain following major operative procedures and for the relief of pain in malignant disease.

Naproxen Suspension 25 mg in 1 mL, is an orange aqueous suspension in bottles of 474 mL used for the treatment of various inflammatory and pain conditions.

Caffeine citrate oral solution.

Monobasic sodium phosphate effervescent tablets used as an oral phosphate supplement in the treatment of hypercalcaemia and hypophosphataemia associated with Vitamin D-resistant rickets.